Jun 03, 2019
Ascentage Pharma presents new clinical data of apoptosis-targeted drug candidates APG-115 and APG-1387 at 2019 ASCO
Apr 11, 2019
Qualigen Enters into Research Agreement for RAS Inhibitor Cancer Drug with University of Louisville (UofL)
Apr 03, 2019
Actinium Highlights Actimab-A and Venetoclax Synergies Observed in New Studies Presented at AACR
Mar 29, 2019
Black Diamond Therapeutics Presents Data From its Program Targeting Oncogenic Allosteric Mutations in EGFR for Glioblastoma as Late Breaker at the American Association for Cancer Research (AACR) Annual Meeting
Mar 25, 2019
Ascentage Pharma Announces Nine Abstracts To Be Presented at the 2019 American Association for Cancer Research Annual Meeting
Feb 26, 2019
Thermo Fisher Scientific's Oncomine Dx Target Test Receives Expanded Regulatory Approval in Japan
Jan 17, 2019
Targovax Granted European Patent for Mutant-RAS Neoantigen Platform Lead Products
Jan 08, 2019
Ascentage Pharma Announces New License with Unity Biotechnology
Jan 03, 2019
REVOLUTION Medicines to Present at the J.P. Morgan Healthcare Conference on January 8, 2019
Dec 19, 2018
Ascentage Pharma Announces Strategic Collaboration with Genor Biopharma
Nov 27, 2018
Roche launches first IVD pan-TRK immunohistochemistry assay
Nov 26, 2018
FDA Approves Vitrakvi® (larotrectinib), the First Ever TRK Inhibitor, for Patients with Advanced Solid Tumors Harboring an NTRK Gene Fusion(1,2)
Oct 23, 2018
New Kind of Compound Shows Early Promise against Prostate Cancer
Sep 24, 2018
Okayama University Research: Insights Into Mechanisms Governing the Resistance to the Anti-Cancer Medication Cetuximab
Jul 17, 2018
Ascentage Pharma Raises $150 Million in Series C Financing
Jun 19, 2018
Targovax Granted EU Patent for Mutant-RAS Neoantigen Platform 2nd Generation Product TG02
May 21, 2018
Ascentage Pharma Announces Promising Phase 1 Interim Results in Two Clinical Programs to Be Presented at 2018 ASCO Annual Meeting
Apr 16, 2018
Head and Neck Cancer Drugs Market Size Worth $1.41 Billion by 2022: Grand View Research, Inc.
Apr 12, 2018
Ascentage Pharma Announces Five Abstracts To Be Presented at the 2018 American Association for Cancer Research Annual Meeting
Feb 26, 2018
Proto Oncogene Market & Clinical Pipeline Insight 2024